The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automated Drug Compounding Systems Market Research Report 2025
Synopsis
An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents.
The global Automated Drug Compounding Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Automated Drug Compounding Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Drug Compounding Systems.
Report Scope
The Automated Drug Compounding Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Drug Compounding Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Drug Compounding Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International Inc.
Braun Melsungen AG
Comecer
ICU MEDICAL INC
Grifols, S.A.
Omnicell
Equashield
ARxIUM
Weibond Technology
NewIcon
Segment by Type
Gravimetric Automated Compounding Systems
Volumetric Automated Compounding Systems
Segment by Application
Hospitals
Chemotherapy Centers
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Drug Compounding Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Drug Compounding Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents.
The global Automated Drug Compounding Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Automated Drug Compounding Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Drug Compounding Systems.
Report Scope
The Automated Drug Compounding Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Drug Compounding Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Drug Compounding Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International Inc.
Braun Melsungen AG
Comecer
ICU MEDICAL INC
Grifols, S.A.
Omnicell
Equashield
ARxIUM
Weibond Technology
NewIcon
Segment by Type
Gravimetric Automated Compounding Systems
Volumetric Automated Compounding Systems
Segment by Application
Hospitals
Chemotherapy Centers
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Drug Compounding Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Drug Compounding Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Automated Drug Compounding Systems Market Overview
1.1 Product Overview and Scope of Automated Drug Compounding Systems
1.2 Automated Drug Compounding Systems Segment by Type
1.2.1 Global Automated Drug Compounding Systems Market Value Comparison by Type (2024-2030)
1.2.2 Gravimetric Automated Compounding Systems
1.2.3 Volumetric Automated Compounding Systems
1.3 Automated Drug Compounding Systems Segment by Application
1.3.1 Global Automated Drug Compounding Systems Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Chemotherapy Centers
1.3.4 Others
1.4 Global Automated Drug Compounding Systems Market Size Estimates and Forecasts
1.4.1 Global Automated Drug Compounding Systems Revenue 2019-2030
1.4.2 Global Automated Drug Compounding Systems Sales 2019-2030
1.4.3 Global Automated Drug Compounding Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Drug Compounding Systems Market Competition by Manufacturers
2.1 Global Automated Drug Compounding Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Drug Compounding Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Drug Compounding Systems Average Price by Manufacturers (2019-2024)
2.4 Global Automated Drug Compounding Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Drug Compounding Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Drug Compounding Systems, Product Type & Application
2.7 Automated Drug Compounding Systems Market Competitive Situation and Trends
2.7.1 Automated Drug Compounding Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Drug Compounding Systems Players Market Share by Revenue
2.7.3 Global Automated Drug Compounding Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Drug Compounding Systems Retrospective Market Scenario by Region
3.1 Global Automated Drug Compounding Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Drug Compounding Systems Global Automated Drug Compounding Systems Sales by Region: 2019-2030
3.2.1 Global Automated Drug Compounding Systems Sales by Region: 2019-2024
3.2.2 Global Automated Drug Compounding Systems Sales by Region: 2025-2030
3.3 Global Automated Drug Compounding Systems Global Automated Drug Compounding Systems Revenue by Region: 2019-2030
3.3.1 Global Automated Drug Compounding Systems Revenue by Region: 2019-2024
3.3.2 Global Automated Drug Compounding Systems Revenue by Region: 2025-2030
3.4 North America Automated Drug Compounding Systems Market Facts & Figures by Country
3.4.1 North America Automated Drug Compounding Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Drug Compounding Systems Sales by Country (2019-2030)
3.4.3 North America Automated Drug Compounding Systems Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Drug Compounding Systems Market Facts & Figures by Country
3.5.1 Europe Automated Drug Compounding Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Drug Compounding Systems Sales by Country (2019-2030)
3.5.3 Europe Automated Drug Compounding Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Drug Compounding Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Drug Compounding Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Drug Compounding Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Drug Compounding Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automated Drug Compounding Systems Market Facts & Figures by Country
3.7.1 Latin America Automated Drug Compounding Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Drug Compounding Systems Sales by Country (2019-2030)
3.7.3 Latin America Automated Drug Compounding Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Drug Compounding Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Drug Compounding Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Drug Compounding Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Drug Compounding Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Drug Compounding Systems Sales by Type (2019-2030)
4.1.1 Global Automated Drug Compounding Systems Sales by Type (2019-2024)
4.1.2 Global Automated Drug Compounding Systems Sales by Type (2025-2030)
4.1.3 Global Automated Drug Compounding Systems Sales Market Share by Type (2019-2030)
4.2 Global Automated Drug Compounding Systems Revenue by Type (2019-2030)
4.2.1 Global Automated Drug Compounding Systems Revenue by Type (2019-2024)
4.2.2 Global Automated Drug Compounding Systems Revenue by Type (2025-2030)
4.2.3 Global Automated Drug Compounding Systems Revenue Market Share by Type (2019-2030)
4.3 Global Automated Drug Compounding Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Drug Compounding Systems Sales by Application (2019-2030)
5.1.1 Global Automated Drug Compounding Systems Sales by Application (2019-2024)
5.1.2 Global Automated Drug Compounding Systems Sales by Application (2025-2030)
5.1.3 Global Automated Drug Compounding Systems Sales Market Share by Application (2019-2030)
5.2 Global Automated Drug Compounding Systems Revenue by Application (2019-2030)
5.2.1 Global Automated Drug Compounding Systems Revenue by Application (2019-2024)
5.2.2 Global Automated Drug Compounding Systems Revenue by Application (2025-2030)
5.2.3 Global Automated Drug Compounding Systems Revenue Market Share by Application (2019-2030)
5.3 Global Automated Drug Compounding Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter International Inc.
6.1.1 Baxter International Inc. Corporation Information
6.1.2 Baxter International Inc. Description and Business Overview
6.1.3 Baxter International Inc. Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter International Inc. Automated Drug Compounding Systems Product Portfolio
6.1.5 Baxter International Inc. Recent Developments/Updates
6.2 Braun Melsungen AG
6.2.1 Braun Melsungen AG Corporation Information
6.2.2 Braun Melsungen AG Description and Business Overview
6.2.3 Braun Melsungen AG Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Braun Melsungen AG Automated Drug Compounding Systems Product Portfolio
6.2.5 Braun Melsungen AG Recent Developments/Updates
6.3 Comecer
6.3.1 Comecer Corporation Information
6.3.2 Comecer Description and Business Overview
6.3.3 Comecer Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Comecer Automated Drug Compounding Systems Product Portfolio
6.3.5 Comecer Recent Developments/Updates
6.4 ICU MEDICAL INC
6.4.1 ICU MEDICAL INC Corporation Information
6.4.2 ICU MEDICAL INC Description and Business Overview
6.4.3 ICU MEDICAL INC Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ICU MEDICAL INC Automated Drug Compounding Systems Product Portfolio
6.4.5 ICU MEDICAL INC Recent Developments/Updates
6.5 Grifols, S.A.
6.5.1 Grifols, S.A. Corporation Information
6.5.2 Grifols, S.A. Description and Business Overview
6.5.3 Grifols, S.A. Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Grifols, S.A. Automated Drug Compounding Systems Product Portfolio
6.5.5 Grifols, S.A. Recent Developments/Updates
6.6 Omnicell
6.6.1 Omnicell Corporation Information
6.6.2 Omnicell Description and Business Overview
6.6.3 Omnicell Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Omnicell Automated Drug Compounding Systems Product Portfolio
6.6.5 Omnicell Recent Developments/Updates
6.7 Equashield
6.6.1 Equashield Corporation Information
6.6.2 Equashield Description and Business Overview
6.6.3 Equashield Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Equashield Automated Drug Compounding Systems Product Portfolio
6.7.5 Equashield Recent Developments/Updates
6.8 ARxIUM
6.8.1 ARxIUM Corporation Information
6.8.2 ARxIUM Description and Business Overview
6.8.3 ARxIUM Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ARxIUM Automated Drug Compounding Systems Product Portfolio
6.8.5 ARxIUM Recent Developments/Updates
6.9 Weibond Technology
6.9.1 Weibond Technology Corporation Information
6.9.2 Weibond Technology Description and Business Overview
6.9.3 Weibond Technology Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Weibond Technology Automated Drug Compounding Systems Product Portfolio
6.9.5 Weibond Technology Recent Developments/Updates
6.10 NewIcon
6.10.1 NewIcon Corporation Information
6.10.2 NewIcon Description and Business Overview
6.10.3 NewIcon Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 NewIcon Automated Drug Compounding Systems Product Portfolio
6.10.5 NewIcon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Drug Compounding Systems Industry Chain Analysis
7.2 Automated Drug Compounding Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Drug Compounding Systems Production Mode & Process
7.4 Automated Drug Compounding Systems Sales and Marketing
7.4.1 Automated Drug Compounding Systems Sales Channels
7.4.2 Automated Drug Compounding Systems Distributors
7.5 Automated Drug Compounding Systems Customers
8 Automated Drug Compounding Systems Market Dynamics
8.1 Automated Drug Compounding Systems Industry Trends
8.2 Automated Drug Compounding Systems Market Drivers
8.3 Automated Drug Compounding Systems Market Challenges
8.4 Automated Drug Compounding Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Automated Drug Compounding Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Automated Drug Compounding Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Automated Drug Compounding Systems Market Competitive Situation by Manufacturers in 2023
Table 4. Global Automated Drug Compounding Systems Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Automated Drug Compounding Systems Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Automated Drug Compounding Systems Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Automated Drug Compounding Systems Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Automated Drug Compounding Systems Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Automated Drug Compounding Systems, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Automated Drug Compounding Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Automated Drug Compounding Systems, Product Type & Application
Table 12. Global Key Manufacturers of Automated Drug Compounding Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Automated Drug Compounding Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automated Drug Compounding Systems as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Automated Drug Compounding Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Automated Drug Compounding Systems Sales by Region (2019-2024) & (K Units)
Table 18. Global Automated Drug Compounding Systems Sales Market Share by Region (2019-2024)
Table 19. Global Automated Drug Compounding Systems Sales by Region (2025-2030) & (K Units)
Table 20. Global Automated Drug Compounding Systems Sales Market Share by Region (2025-2030)
Table 21. Global Automated Drug Compounding Systems Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Automated Drug Compounding Systems Revenue Market Share by Region (2019-2024)
Table 23. Global Automated Drug Compounding Systems Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Automated Drug Compounding Systems Revenue Market Share by Region (2025-2030)
Table 25. North America Automated Drug Compounding Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Automated Drug Compounding Systems Sales by Country (2019-2024) & (K Units)
Table 27. North America Automated Drug Compounding Systems Sales by Country (2025-2030) & (K Units)
Table 28. North America Automated Drug Compounding Systems Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Automated Drug Compounding Systems Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Automated Drug Compounding Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Automated Drug Compounding Systems Sales by Country (2019-2024) & (K Units)
Table 32. Europe Automated Drug Compounding Systems Sales by Country (2025-2030) & (K Units)
Table 33. Europe Automated Drug Compounding Systems Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Automated Drug Compounding Systems Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Automated Drug Compounding Systems Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Automated Drug Compounding Systems Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Automated Drug Compounding Systems Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Automated Drug Compounding Systems Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Automated Drug Compounding Systems Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Automated Drug Compounding Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Automated Drug Compounding Systems Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Automated Drug Compounding Systems Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Automated Drug Compounding Systems Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Automated Drug Compounding Systems Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Automated Drug Compounding Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Automated Drug Compounding Systems Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Automated Drug Compounding Systems Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Automated Drug Compounding Systems Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Automated Drug Compounding Systems Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Automated Drug Compounding Systems Sales (K Units) by Type (2019-2024)
Table 51. Global Automated Drug Compounding Systems Sales (K Units) by Type (2025-2030)
Table 52. Global Automated Drug Compounding Systems Sales Market Share by Type (2019-2024)
Table 53. Global Automated Drug Compounding Systems Sales Market Share by Type (2025-2030)
Table 54. Global Automated Drug Compounding Systems Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Automated Drug Compounding Systems Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Automated Drug Compounding Systems Revenue Market Share by Type (2019-2024)
Table 57. Global Automated Drug Compounding Systems Revenue Market Share by Type (2025-2030)
Table 58. Global Automated Drug Compounding Systems Price (US$/Unit) by Type (2019-2024)
Table 59. Global Automated Drug Compounding Systems Price (US$/Unit) by Type (2025-2030)
Table 60. Global Automated Drug Compounding Systems Sales (K Units) by Application (2019-2024)
Table 61. Global Automated Drug Compounding Systems Sales (K Units) by Application (2025-2030)
Table 62. Global Automated Drug Compounding Systems Sales Market Share by Application (2019-2024)
Table 63. Global Automated Drug Compounding Systems Sales Market Share by Application (2025-2030)
Table 64. Global Automated Drug Compounding Systems Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Automated Drug Compounding Systems Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Automated Drug Compounding Systems Revenue Market Share by Application (2019-2024)
Table 67. Global Automated Drug Compounding Systems Revenue Market Share by Application (2025-2030)
Table 68. Global Automated Drug Compounding Systems Price (US$/Unit) by Application (2019-2024)
Table 69. Global Automated Drug Compounding Systems Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter International Inc. Corporation Information
Table 71. Baxter International Inc. Description and Business Overview
Table 72. Baxter International Inc. Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter International Inc. Automated Drug Compounding Systems Product
Table 74. Baxter International Inc. Recent Developments/Updates
Table 75. Braun Melsungen AG Corporation Information
Table 76. Braun Melsungen AG Description and Business Overview
Table 77. Braun Melsungen AG Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Braun Melsungen AG Automated Drug Compounding Systems Product
Table 79. Braun Melsungen AG Recent Developments/Updates
Table 80. Comecer Corporation Information
Table 81. Comecer Description and Business Overview
Table 82. Comecer Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Comecer Automated Drug Compounding Systems Product
Table 84. Comecer Recent Developments/Updates
Table 85. ICU MEDICAL INC Corporation Information
Table 86. ICU MEDICAL INC Description and Business Overview
Table 87. ICU MEDICAL INC Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. ICU MEDICAL INC Automated Drug Compounding Systems Product
Table 89. ICU MEDICAL INC Recent Developments/Updates
Table 90. Grifols, S.A. Corporation Information
Table 91. Grifols, S.A. Description and Business Overview
Table 92. Grifols, S.A. Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Grifols, S.A. Automated Drug Compounding Systems Product
Table 94. Grifols, S.A. Recent Developments/Updates
Table 95. Omnicell Corporation Information
Table 96. Omnicell Description and Business Overview
Table 97. Omnicell Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Omnicell Automated Drug Compounding Systems Product
Table 99. Omnicell Recent Developments/Updates
Table 100. Equashield Corporation Information
Table 101. Equashield Description and Business Overview
Table 102. Equashield Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Equashield Automated Drug Compounding Systems Product
Table 104. Equashield Recent Developments/Updates
Table 105. ARxIUM Corporation Information
Table 106. ARxIUM Description and Business Overview
Table 107. ARxIUM Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. ARxIUM Automated Drug Compounding Systems Product
Table 109. ARxIUM Recent Developments/Updates
Table 110. Weibond Technology Corporation Information
Table 111. Weibond Technology Description and Business Overview
Table 112. Weibond Technology Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Weibond Technology Automated Drug Compounding Systems Product
Table 114. Weibond Technology Recent Developments/Updates
Table 115. NewIcon Corporation Information
Table 116. NewIcon Description and Business Overview
Table 117. NewIcon Automated Drug Compounding Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. NewIcon Automated Drug Compounding Systems Product
Table 119. NewIcon Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Automated Drug Compounding Systems Distributors List
Table 123. Automated Drug Compounding Systems Customers List
Table 124. Automated Drug Compounding Systems Market Trends
Table 125. Automated Drug Compounding Systems Market Drivers
Table 126. Automated Drug Compounding Systems Market Challenges
Table 127. Automated Drug Compounding Systems Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Automated Drug Compounding Systems
Figure 2. Global Automated Drug Compounding Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Automated Drug Compounding Systems Market Share by Type in 2023 & 2030
Figure 4. Gravimetric Automated Compounding Systems Product Picture
Figure 5. Volumetric Automated Compounding Systems Product Picture
Figure 6. Global Automated Drug Compounding Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Automated Drug Compounding Systems Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Chemotherapy Centers
Figure 10. Others
Figure 11. Global Automated Drug Compounding Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Automated Drug Compounding Systems Market Size (2019-2030) & (US$ Million)
Figure 13. Global Automated Drug Compounding Systems Sales (2019-2030) & (K Units)
Figure 14. Global Automated Drug Compounding Systems Average Price (US$/Unit) & (2019-2030)
Figure 15. Automated Drug Compounding Systems Report Years Considered
Figure 16. Automated Drug Compounding Systems Sales Share by Manufacturers in 2023
Figure 17. Global Automated Drug Compounding Systems Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Automated Drug Compounding Systems Players: Market Share by Revenue in 2023
Figure 19. Automated Drug Compounding Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Automated Drug Compounding Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Automated Drug Compounding Systems Sales Market Share by Country (2019-2030)
Figure 22. North America Automated Drug Compounding Systems Revenue Market Share by Country (2019-2030)
Figure 23. United States Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Automated Drug Compounding Systems Sales Market Share by Country (2019-2030)
Figure 26. Europe Automated Drug Compounding Systems Revenue Market Share by Country (2019-2030)
Figure 27. Germany Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Automated Drug Compounding Systems Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Automated Drug Compounding Systems Revenue Market Share by Region (2019-2030)
Figure 34. China Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Automated Drug Compounding Systems Sales Market Share by Country (2019-2030)
Figure 44. Latin America Automated Drug Compounding Systems Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Automated Drug Compounding Systems Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Automated Drug Compounding Systems Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Automated Drug Compounding Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Automated Drug Compounding Systems by Type (2019-2030)
Figure 54. Global Revenue Market Share of Automated Drug Compounding Systems by Type (2019-2030)
Figure 55. Global Automated Drug Compounding Systems Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Automated Drug Compounding Systems by Application (2019-2030)
Figure 57. Global Revenue Market Share of Automated Drug Compounding Systems by Application (2019-2030)
Figure 58. Global Automated Drug Compounding Systems Price (US$/Unit) by Application (2019-2030)
Figure 59. Automated Drug Compounding Systems Value Chain
Figure 60. Automated Drug Compounding Systems Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
